Fly News Breaks for July 12, 2019
Jul 12, 2019 | 05:22 EDT
Piper Jaffray analyst Matt O'Brien "strongly" encourages purchase of SeaSpine Holdings shares after the company announced the full commercial launch of Regatta, a lateral interbody device featuring the company's proprietary NanoMetalene technology. . This launch, the full launch of Mariner expected in Q3, as well as several other hardware and biologics expected later this year should position SeaSpine to continue its string of quarterly beats, O'Brien tells investors in a research note. He reiterates an Overweight rating on the name with a $20 price target.
News For SPNE From the Last 2 Days
There are no results for your query SPNE